Skip to main content

View full-text article in PMC

. 2021 Nov 16;13(11):e19639. doi: 10.7759/cureus.19639

Table 4. The Effects of Androgen Ablation.

^a Significant difference by androgen ablation

^b Significant change through time

⁺ No significant difference by surgical status for CRP, WBC, or Lymphocytes

RT: Radiotherapy; PSA: Prostate-specific antigen; CRP: C-reactive protein; WBC: White blood cells; AA: Androgen ablation.

		With Androgen Ablation (n=106)	Without Androgen Ablation (n=103)
		Median (range)	Median (range)	p-value
pre-RT PSA (all) +		0.9 (0-30.2)	2.85 (0.0-39.9)	0.0072^a
	no surgery	1.0 (0.0-30.2)	7.4 (0.4-39.9)	<0.0001^a
	surgery	0.0 (0.0-3.1)	0.2 (0.0-2.0)	0.7116
pre-RT CRP		2.35 (0-35.2)	2.85 (0.2-15.7)	0.7593
pre-RT WBC		6.3 (3-14.8)	6.55 (3.9-12.1)	0.5899
pre-RT Lymphocytes		1.82 (0.6-5.0)	1.94 (0.8-5.0)	0.3101
δpre-AA-->pre-RT PSA (all) +		-7.2 (-125.3-1.1)	N/A	<0.0001^b
	no surgery	-8.1 (-125.3-1.1)		<0.0001^b
	surgery	-0.75 (-20.7-0.1)		0.0156^b
δpre-AA-->pre-RT CRP		-0.05 (-66.1-21.5)		0.646
δpre-AA-->pre-RT WBC		-0.1 (-5.8-4.4)		0.3598
δpre-AA-->pre-RT Lymphocytes		0.0 (-2.6-1.2)		0.9717